RecallDepth
Class II Ongoing

Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC 13107-283-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
April 24, 2024
Posted
May 15, 2024
Recall Number
D-0492-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6909 bottles
Firm Location
East Windsor, NJ, United States

Reason for Recall

Discoloration: Dotted and yellow spots on tablets

Distribution

Nationwide in the USA

Lot / Code Info

Lot #s: a) CZB124001B, CZB124002B, CZB124003B, Exp. 12/31/2025; b) CZB124001A, CZB124003A, Exp. 12/31/2025.

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls